FLASH-AWAY: Intrabody-Directed Targeting of Optogenetic Tools for Protein Degradation

Zirui Zhuang1,2, Ran Li1,3, Bing Wang1,3

  • 1Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310018, China.

ACS Synthetic Biology
|November 24, 2025
PubMed

Insights

Scientists developed Flash-Away, a novel optogenetic tool for precise protein degradation. This light-inducible system rapidly depletes targeted proteins, offering new avenues for disease research and precision medicine.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biotechnology

Background:

  • Protein homeostasis (proteostasis) is vital for cellular function and health.
  • Abnormal protein accumulation is linked to diseases like cancer.
  • Existing methods for protein modulation lack precision and cannot degrade existing proteins.

Purpose of the Study:

  • To develop a novel tool for precise, light-inducible control of protein degradation.
  • To overcome limitations of current genetic and molecular tools for protein modulation.

Main Methods:

  • Introduction of Flash-Away, an intrabody-based optogenetic toolbox.
  • Integration of light-responsive ubiquitination (TRIM21 RING domain) with specific intrabodies.
  • Application of blue light to induce targeted protein degradation.

Main Results:

  • Flash-Away enables rapid and targeted degradation of selected proteins.
  • Demonstrated versatility with diverse targets: actin, MLKL, and ALFA-tag fused proteins.
  • Successful application of a light-inducible protein degradation system.

Conclusions:

  • Flash-Away provides a powerful method for investigating protein function in physiological contexts.
  • The system holds potential for clinical translational research and precision medicine.
  • Advances prospects for precise medical interventions through optogenetic control of protein degradation.